8-KMaterial AgreementsShareholder MattersCorporate Changes+1

OCCIDENTAL PETROLEUM CORP /DE/ 8-K Report, Material Agreement (Mar 13, 2020)

Filed March 13, 2020For Securities:OXYOXY-WT

Summary

Occidental Petroleum Corporation (OXY) announced on March 13, 2020, the adoption of a shareholder rights plan, commonly known as a 'poison pill.' This plan involves issuing one preferred share purchase right (a 'Right') for each outstanding share of common stock. These Rights are designed to deter hostile takeovers and coercive tactics by allowing existing shareholders to purchase preferred stock at a discounted price if a party acquires a significant stake (15% or 20% for passive institutional investors) without the board's approval. The primary objective is to protect stockholders from attempts to capitalize on current market volatility and macroeconomic conditions to gain control of the company on unfavorable terms. The plan is subject to shareholder approval at the 2020 annual meeting, and if not approved, the Rights will expire. If approved, the Rights Agreement will generally be in effect for one year. The adoption of this plan aims to provide the Board with sufficient time and leverage to make informed decisions and ensure any potential acquisition offers fair compensation to all stockholders.

Key Highlights

  • 1Adoption of a shareholder rights plan ('poison pill') effective March 12, 2020.
  • 2Dividend of one preferred share purchase right per outstanding common share declared.
  • 3Rights become exercisable if an 'Acquiring Person' accumulates 15% (or 20% for passive institutional investors) of OXY's common stock without board approval.
  • 4Upon triggering, Rights holders can purchase OXY common stock worth double the exercise price, causing significant dilution to the acquirer.
  • 5The plan aims to protect against hostile takeovers, especially during periods of market volatility.
  • 6The Rights Agreement and dividend are subject to approval by OXY's stockholders at the 2020 annual meeting.
  • 7The Rights Agreement has an initial expiration date of March 11, 2021, or upon shareholder meeting outcome, and if approved, typically lasts one year.

Frequently Asked Questions